Clinical Trial Update: A Mild Supplementation of Arabinoxylan Fiber Improves Homa Index in Overweight and Obese Subjects. [NA]

View source ↗

Summary

A clinical trial update suggests that mild arabinoxylan fiber supplementation improves the HOMA index in overweight and obese adults. The study status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome
• Obesity

Drugs mentioned

• Arabinoxylan fiber (arabinoxylan fiber)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Nutritional and Metabolic Diseases | NA | Status: UNKNOWN